Immediate Impact

4 from Science/Nature 70 standout
Sub-graph 1 of 19

Citing Papers

Phase 3 Trial of Semaglutide in Metabolic Dysfunction–Associated Steatohepatitis
2025 Standout
Metabolic Dysfunction–Associated Steatotic Liver Disease (MASLD) in People With Diabetes: The Need for Screening and Early Intervention. A Consensus Report of the American Diabetes Association
2025 Standout
18 intermediate papers

Works of Nigel Girgrah being referenced

Screening for Nonalcoholic Fatty Liver Disease in Persons with Type 2 Diabetes in the United States Is Cost-effective: A Comprehensive Cost-Utility Analysis
2020
The cardiac response to exercise in cirrhosis
2001
and 1 more

Author Peers

Author Last Decade Papers Cites
Nigel Girgrah 1201 775 767 37 1.5k
Oded Jurim 745 843 437 65 1.5k
Christine A. O’Mahony 761 1000 531 80 1.9k
René Romero 752 1132 542 75 1.7k
George E. Loss 903 773 578 51 1.5k
J. Jeffrey Malatack 502 816 311 42 1.8k
Sukru Emre 1000 1304 603 45 1.9k
Robert J. Porte 909 924 471 50 1.7k
Herman G. D. Hendriks 768 782 382 25 1.7k
Waldo Concepcion 588 825 399 61 1.5k
Cataldo Doria 525 935 258 60 1.5k

All Works

Loading papers...

Rankless by CCL
2026